BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34875562)

  • 1. VPS13C-associated Parkinson's disease: Two novel cases and review of the literature.
    Monfrini E; Spagnolo F; Canesi M; Seresini A; Rini A; Passarella B; Percetti M; Seia M; Goldwurm S; Cereda V; Comi GP; Pezzoli G; Di Fonzo A
    Parkinsonism Relat Disord; 2022 Jan; 94():37-39. PubMed ID: 34875562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.
    Smolders S; Philtjens S; Crosiers D; Sieben A; Hens E; Heeman B; Van Mossevelde S; Pals P; Asselbergh B; Dos Santos Dias R; Vermeiren Y; Vandenberghe R; Engelborghs S; De Deyn PP; Martin JJ; Cras P; Annaert W; Van Broeckhoven C;
    Acta Neuropathol Commun; 2021 Feb; 9(1):25. PubMed ID: 33579389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation screening and burden analysis of VPS13C in Chinese patients with early-onset Parkinson's disease.
    Gu X; Li C; Chen Y; Ou R; Cao B; Wei Q; Hou Y; Zhang L; Song W; Zhao B; Wu Y; Shang H
    Neurobiol Aging; 2020 Oct; 94():311.e1-311.e4. PubMed ID: 32507414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.
    Quadri M; Mandemakers W; Grochowska MM; Masius R; Geut H; Fabrizio E; Breedveld GJ; Kuipers D; Minneboo M; Vergouw LJM; Carreras Mascaro A; Yonova-Doing E; Simons E; Zhao T; Di Fonzo AB; Chang HC; Parchi P; Melis M; Correia Guedes L; Criscuolo C; Thomas A; Brouwer RWW; Heijsman D; Ingrassia AMT; Calandra Buonaura G; Rood JP; Capellari S; Rozemuller AJ; Sarchioto M; Fen Chien H; Vanacore N; Olgiati S; Wu-Chou YH; Yeh TH; Boon AJW; Hoogers SE; Ghazvini M; IJpma AS; van IJcken WFJ; Onofrj M; Barone P; Nicholl DJ; Puschmann A; De Mari M; Kievit AJ; Barbosa E; De Michele G; Majoor-Krakauer D; van Swieten JC; de Jong FJ; Ferreira JJ; Cossu G; Lu CS; Meco G; Cortelli P; van de Berg WDJ; Bonifati V;
    Lancet Neurol; 2018 Jul; 17(7):597-608. PubMed ID: 29887161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.
    Lesage S; Drouet V; Majounie E; Deramecourt V; Jacoupy M; Nicolas A; Cormier-Dequaire F; Hassoun SM; Pujol C; Ciura S; Erpapazoglou Z; Usenko T; Maurage CA; Sahbatou M; Liebau S; Ding J; Bilgic B; Emre M; Erginel-Unaltuna N; Guven G; Tison F; Tranchant C; Vidailhet M; Corvol JC; Krack P; Leutenegger AL; Nalls MA; Hernandez DG; Heutink P; Gibbs JR; Hardy J; Wood NW; Gasser T; Durr A; Deleuze JF; Tazir M; Destée A; Lohmann E; Kabashi E; Singleton A; Corti O; Brice A; ;
    Am J Hum Genet; 2016 Mar; 98(3):500-513. PubMed ID: 26942284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.
    Proukakis C; Shoaee M; Morris J; Brier T; Kara E; Sheerin UM; Charlesworth G; Tolosa E; Houlden H; Wood NW; Schapira AH
    Mov Disord; 2014 Jul; 29(8):1060-4. PubMed ID: 24752924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and neuropathological characteristics of dementia with Lewy bodies].
    Bencze J; Simon V; Bereczki E; Majer R; Varkoly G; Murnyák B; Kálmán J; Hortobágyi T
    Orv Hetil; 2017 Apr; 158(17):643-652. PubMed ID: 28434243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the LRP10 gene in patients with Parkinson's disease and dementia with Lewy bodies from Southern Italy.
    Gagliardi M; Procopio R; Nicoletti G; Morelli M; D'Amelio M; Quattrone A; Annesi G
    Neurol Sci; 2021 Jan; 42(1):305-308. PubMed ID: 32995992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
    Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease.
    Goldmann Gross R; Siderowf A; Hurtig HI
    Neurosignals; 2008; 16(1):24-34. PubMed ID: 18097157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson's disease and de novo dementia with Lewy bodies.
    Oka H; Umehara T; Nakahara A; Matsuno H
    BMC Neurol; 2020 Sep; 20(1):350. PubMed ID: 32948137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.
    Orad RI; Shiner T
    J Neurol; 2022 Feb; 269(2):639-653. PubMed ID: 33511432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRP10 variants in Parkinson's disease and dementia with Lewy bodies in the South-West of the Netherlands.
    Vergouw LJM; Ruitenberg A; Wong TH; Melhem S; Breedveld GJ; Criscuolo C; De Michele G; de Jong FJ; Bonifati V; van Swieten JC; Quadri M
    Parkinsonism Relat Disord; 2019 Aug; 65():243-247. PubMed ID: 31147221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.
    Brockmann K; Quadalti C; Lerche S; Rossi M; Wurster I; Baiardi S; Roeben B; Mammana A; Zimmermann M; Hauser AK; Deuschle C; Schulte C; Waniek K; Lachmann I; Sjödin S; Brinkmalm A; Blennow K; Zetterberg H; Gasser T; Parchi P
    Acta Neuropathol Commun; 2021 Oct; 9(1):175. PubMed ID: 34717775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!
    Friedman JH
    Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S6-S9. PubMed ID: 28756177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic association study of synphilin-1 in idiopathic Parkinson's disease.
    Myhre R; Klungland H; Farrer MJ; Aasly JO
    BMC Med Genet; 2008 Mar; 9():19. PubMed ID: 18366718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease.
    Morris CM; O'Brien KK; Gibson AM; Hardy JA; Singleton AB
    Neurosci Lett; 2003 Dec; 352(2):151-3. PubMed ID: 14625045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.